Business · 17/08/2022
FDA Grants Hearing on Covis Pharma Group's Proposal to Withdraw Approval of MAKENA
The FDA has scheduled a hearing to discuss Covis Pharma Group's proposal to withdraw approval of MAKENA, a new drug application, following a request from the Center for Drug Evaluation and Research.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →